These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 17204292
1. Endogenous angiotensin II enhances atherogenesis in apoprotein E-deficient mice with renovascular hypertension through activation of vascular smooth muscle cells. Heo HJ, Yun MR, Jung KH, Lee JY, Park JY, Lee SJ, Bae SS, Lee WS, Kim CD. Life Sci; 2007 Feb 20; 80(11):1057-63. PubMed ID: 17204292 [Abstract] [Full Text] [Related]
2. Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice. Fabrizio Rodella L, Bonomini F, Rezzani R, Tengattini S, Hayek T, Aviram M, Keidar S, Coleman R, Bianchi R. Acta Histochem; 2007 Feb 20; 109(1):45-51. PubMed ID: 17046051 [Abstract] [Full Text] [Related]
3. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Hechler B, Freund M, Ravanat C, Magnenat S, Cazenave JP, Gachet C. Circulation; 2008 Aug 12; 118(7):754-63. PubMed ID: 18663083 [Abstract] [Full Text] [Related]
4. Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect. Castoldi G, di Gioia CR, Travaglini C, Busca G, Redaelli S, Bombardi C, Stella A. Clin Exp Pharmacol Physiol; 2007 Mar 12; 34(3):205-9. PubMed ID: 17250640 [Abstract] [Full Text] [Related]
5. Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. Nogueira BV, Peotta VA, Meyrelles SS, Vasquez EC. Arch Med Res; 2007 Nov 12; 38(8):816-21. PubMed ID: 17923260 [Abstract] [Full Text] [Related]
6. Angiotensin II amplifies macrophage-driven atherosclerosis. Nobuhiko A, Suganuma E, Babaev VR, Fogo A, Swift LL, Linton MF, Fazio S, Ichikawa I, Kon V. Arterioscler Thromb Vasc Biol; 2004 Nov 12; 24(11):2143-8. PubMed ID: 15374850 [Abstract] [Full Text] [Related]
7. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice. Liu SL, Li YH, Shi GY, Tang SH, Jiang SJ, Huang CW, Liu PY, Hong JS, Wu HL. Cardiovasc Res; 2009 Apr 01; 82(1):161-9. PubMed ID: 19189960 [Abstract] [Full Text] [Related]
8. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Mercer J, Figg N, Stoneman V, Braganza D, Bennett MR. Circ Res; 2005 Apr 01; 96(6):667-74. PubMed ID: 15746445 [Abstract] [Full Text] [Related]
9. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH. Circulation; 2007 May 08; 115(18):2442-50. PubMed ID: 17438151 [Abstract] [Full Text] [Related]
10. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype. Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A. Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412 [Abstract] [Full Text] [Related]
11. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice. Zhou Y, Chen R, Catanzaro SE, Hu L, Dansky HM, Catanzaro DF. Am J Hypertens; 2005 Apr 25; 18(4 Pt 1):486-92. PubMed ID: 15831357 [Abstract] [Full Text] [Related]
12. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Wang Y, Zhao X, Jin H, Wei H, Li W, Bu D, Tang X, Ren Y, Tang C, Du J. Arterioscler Thromb Vasc Biol; 2009 Feb 25; 29(2):173-9. PubMed ID: 18988885 [Abstract] [Full Text] [Related]
13. Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway. Limor R, Kaplan M, Sawamura T, Sharon O, Keidar S, Weisinger G, Knoll E, Naidich M, Stern N. Am J Hypertens; 2005 Mar 25; 18(3):299-307. PubMed ID: 15797645 [Abstract] [Full Text] [Related]
14. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Kunieda T, Minamino T, Nishi J, Tateno K, Oyama T, Katsuno T, Miyauchi H, Orimo M, Okada S, Takamura M, Nagai T, Kaneko S, Komuro I. Circulation; 2006 Aug 29; 114(9):953-60. PubMed ID: 16908765 [Abstract] [Full Text] [Related]
15. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension. Sendra J, Llorente-Cortés V, Costales P, Huesca-Gómez C, Badimon L. Cardiovasc Res; 2008 Jun 01; 78(3):581-9. PubMed ID: 18281370 [Abstract] [Full Text] [Related]
16. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. Coleman R, Hayek T, Keidar S, Aviram M. Acta Histochem; 2006 Jun 01; 108(6):415-24. PubMed ID: 17007910 [Abstract] [Full Text] [Related]
17. Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice. Yamanouchi D, Morgan S, Kato K, Lengfeld J, Zhang F, Liu B. Arterioscler Thromb Vasc Biol; 2010 Apr 01; 30(4):702-7. PubMed ID: 20075419 [Abstract] [Full Text] [Related]
18. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice. Hu Q, Zhang XJ, Liu CX, Wang XP, Zhang Y. J Vasc Res; 2010 Apr 01; 47(1):69-79. PubMed ID: 19729954 [Abstract] [Full Text] [Related]
19. Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. Salguero G, Akin E, Templin C, Kotlarz D, Doerries C, Landmesser U, Grote K, Schieffer B. J Hypertens; 2008 Feb 01; 26(2):257-68. PubMed ID: 18192840 [Abstract] [Full Text] [Related]
20. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice. Shiraishi Y, Watanabe T, Suguro T, Nagashima M, Kato R, Hongo S, Itabe H, Miyazaki A, Hirano T, Adachi M. J Hypertens; 2008 Oct 01; 26(10):1955-65. PubMed ID: 18806619 [Abstract] [Full Text] [Related] Page: [Next] [New Search]